Fig. 2
From: Remnant cholesterol is an effective biomarker for predicting survival in patients with breast cancer
The Kaplan–Meier curves of breast cancer patients with low or high remnant cholesterol. (A) total population; (B) patients < 50 years; (C) patients ≥ 50 years; (D) stage I–II patients; (E) stage III patients; (F) stage IV patients; (G) underweight patients; (H) normal weight patients; (I) overweight patients